INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
HOUSE PTR/PurchaseVerified data

Gilbert Ray Cisneros, Jr. bought BBIO

Self · BridgeBio Pharma, Inc. · BridgeBio Pharma, Inc. - Common Stock

Side
BUY
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
May 11, 2026
Disclosed
Jun 8, 2026
Disclosure timeline28 days from execution to publication · legal deadline 45 days
May 11 executedJun 8, 2026 disclosed

BBIO · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
20/ 100 · ROUTINE
Methodology →
  • Transaction type+14 / 20

    Purchase

  • Relative size+2 / 25

    Disclosed range starting at $1K

  • Filing timing0 / 15

    Disclosed 28 days after execution (STOCK Act deadline: 45)

  • Historical behavior+4 / 15

    4 prior trades recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BBIO

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    27
    Gilbert Ray Cisneros, Jr.DSelf
    BBIOBridgeBio Pharma, Inc.
    Partial sale
    		SELL$1,001 – $15KSep 29, 2026Oct 12, 2026
    traded Sep 29, 2026
    		+13dHOUSE PTR

    Evidence

    20
    Gilbert Ray Cisneros, Jr.DSelf
    BBIOBridgeBio Pharma, Inc.
    Purchase
    		BUY$1,001 – $15KApr 29, 2026May 8, 2026
    traded Apr 29, 2026
    		+9dHOUSE PTR

    Evidence

    28
    Gilbert Ray Cisneros, Jr.DSelf
    BBIOBridgeBio Pharma, Inc.
    Purchase
    		BUY$1,001 – $15KMar 3, 2026Apr 7, 2026
    traded Mar 3, 2026
    		+35dHOUSE PTR

    Evidence

    20
    Gilbert Ray Cisneros, Jr.DSelf
    BBIOBridgeBio Pharma, Inc.
    Purchase
    		BUY$1,001 – $15KMar 19, 2026Apr 7, 2026
    traded Mar 19, 2026
    		+19dHOUSE PTR

    Evidence

    20
    Gilbert Ray Cisneros, Jr.DSelf
    BBIOBridgeBio Pharma, Inc.
    Purchase
    		BUY$1,001 – $15KMar 18, 2026Apr 7, 2026
    traded Mar 18, 2026
    		+20dHOUSE PTR

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20034713

    Timestamps

    Event (reported)
    May 11, 2026
    Published
    Jun 8, 2026
    Ingested by INSIDER
    Nov 5, 00:34 UTC
    Last re-read
    Nov 5, 06:47 UTC

    Extracted facts

    Filer
    Gilbert Ray Cisneros, Jr.
    Role
    Self
    Transaction
    PurchaseAs filed: “P”
    Asset
    BridgeBio Pharma, Inc. - Common Stock
    Ticker
    BBIO
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    May 11, 2026
    Notification date (reported)
    Jun 5, 2026
    Days from execution to publication
    28

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    Gilbert Ray Cisneros, Jr. reported a purchase of BridgeBio Pharma, Inc. - Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Self
    Gilbert Ray Cisneros, Jr.bioguide:C001123
    Issuer
    BridgeBio Pharma, Inc.cik:0001743881

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.